A comparison of the sedative, hemodynamic, and respiratory effects of dexmedetomidine and propofol in children undergoing magnetic resonance imaging

Anesthesia and Analgesia

Volumn 103, Issue 1, 2006, Pages 63-67

  Koroglu, Ahmet ^a   Teksan, Huseyin ^b   Sagir, Ozlem ^a   Yucel, Aytaç ^a   Toprak, Huseyin I ^a   Ersoy, Ozcan M ^a  

^a INONU UNIVERSITY   (Turkey)

^b Group of Vatan's Hospital   (Turkey)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA 2 ADRENERGIC RECEPTOR STIMULATING AGENT; ARITMAL; DEXMEDETOMIDINE; EMLA; LIDOCAINE; PROPOFOL;

ANESTHETIC RECOVERY; ARTICLE; BRADYCARDIA; BREATHING RATE; CHILD; CLINICAL TRIAL; DIAGNOSTIC IMAGING; DRUG EFFECT; DRUG INFUSION; FEMALE; HEART RATE; HEMODYNAMIC PARAMETERS; HUMAN; HYPOTENSION; INJECTION SITE PAIN; MAJOR CLINICAL STUDY; MALE; MEAN ARTERIAL PRESSURE; NUCLEAR MAGNETIC RESONANCE IMAGING; OXYGEN SATURATION; PEDIATRIC ANESTHESIA; PRIORITY JOURNAL; RAMSAY SEDATION SCALE; RATING SCALE; RESPIRATION DEPRESSION; SCORING SYSTEM; SEDATION;

EID: 33745820883     PISSN: 00032999     EISSN: None     Source Type: Journal    
DOI: 10.1213/01.ANE.0000219592.82598.AA     Document Type: Article

References (25)

1. Lawson GR. Sedation of children for magnetic resonance imaging. Arch Dis Child 2000;82:150-2.
2. Hasan RA, Shayevitz JR, Patel V. Deep sedation with propofol for children undergoing ambulatory magnetic resonance imaging of the brain: Experience from a pediatric intensive care unit. Pediatr Crit Care Med 2003;4:454-8.
3. Bluemke DA, Breiter SN. Sedation procedures in MR imaging: safety, effectiveness, and nursing effect on examinations. Radiology 2000;216:645-52.
4. Malviya S, Voepel LT, Eldevik OP, et al. Sedation and general anaesthesia in children undergoing MRI and CT: adverse events and outcomes. Br J Anaesth 2000;84:743-8.
5. Dial S, Silver P, Bock K, Sagy M. Pediatric sedation for procedures titrated to desired degree of immobility results in unpredictable depth of sedation. Pediatr Emerg Care 2001;17:414-20.
6. Bhana KNL, McClellan GJ, McClellan KJ. Dexmedetomidine. Drugs 2000;59:263-8.
7. Shelly MP. Dexmedetomidine: a real innovation or more of the same? Br J Anaesth 2001;87:677-8.
8. Nelson LE, Lu J, Guo T, et al. The alpha2-adrenoceptor agonist dexmedetomidine converges on an endogenous sleep-promoting pathway to exert its sedative effects. Anesthesiology 2003;98:428-36.
9. Koroglu A, Demirbilek S, Teksan H, et al. Sedative, hemodynamic and respiratory effects of dexmedetomidine in children undergoing magnetic resonance imaging examination: preliminary results. Br J Anaesth 2005;94:821-4.
10. Frankville DD, Spear RM, Dyck JB. The dose of propofol required to prevent children from moving during magnetic resonance imaging. Anesthesiology 1993;79:953-8.
11. Usher GA, Kearney RA, Tsui BCH. Propofol total intravenous anesthesia for MRI in children. Paediatr Anaesth 2005;15:23-8.
12. Voepel LT, Malviya S, Prochaska G, Tait RA. Sedation failures in children undergoing MRI and CT: is temperament a factor? Paediatr Anaesth 2000;10:319-23.
13. Hall JE, Ulrich TD, Barney JA, et al. Sedative, amnestic and analgesic properties of small-dose dexmedetomidine infusions. Anesth Analg 2000;90:699-705.
14. Tobias JD, Berkenbosch JW. Initial experience with dexmedetomidine in paediatric-aged patients. Paediatr Anaesth 2002;12:171-5.
15. Tobias JD, Berkenbosch JW, Russo P. Additional experience with dexmedetomidine in pediatric patients. South Med J 2003;96:871-5.
16. Triltsch AE, Weite M, Von Homeyer P, et al. Bispectral index-guided sedation with dexmedetomidine in intensive care: randomized, double blind, placebo-controlled phase II study. Crit Care Med 2002;30:1007-14.
17. Bloomfield EL, Masaryk TJ, Caplin A, et al. Intravenous sedation for MR imaging of the brain and spine in children: pentobarbital versus propofol. Pediatr Radiol 1993;186:93-7.
18. Venn RM, Bradshaw CJ, Spencer R, et al. Preliminary UK experience of dexmedetomidine, a novel agent for postoperative sedation in the intensive care unit. Anaesthesia 1999;54:1136-42.
19. Ebert TJ, Hall JE, Barney JA, et al. The effects of increasing plasma concentrations of dexmedetomidine in humans. Anesthesiology 2000;93:382-94.
20. Venn RM, Karol MD, Grounds RM. Pharmacokinetics of dexmedetomidine infusions for sedation of postoperative patients requiring intensive care. Br J Anaesth 2002;88:669-75.
21. Kallio A, Scheinin M, Koulu M, et al. Effects of dexmedetomidine, a selective alpha2-adrenoceptor agonist, on hemodynamic control mechanisms. Clin Pharmacol Ther 1989;49:33-42.
22. Aun CS. New i.v. agents. Br J Anaesth 1999;83:29-41.
23. Tramer MR, Moore RA, McQuay HJ. Propofol and bradycardia: causation, frequency and severity. Br J Anaesth 1997;78:642-51.
24. Venn RM, Hell J, Grounds RM. Respiratory effects of dexmedetomidine in the surgical patient requiring intensive care. Crit Care 2000;4:302-8.
25. Belleville JP, Wards DS, Bloor BC, Maze M. Effects of intravenous dexmedetomidine in human: sedation, ventilation and metabolic rate. Anesthesiology 1992;77:1125-33.